In conclusion, comprehensive analysis of IFN related gene showed that dysregulation of the IFN system might be related to treatment failure and that IFN related gene expression before treatment can enable accurate prediction of CH combination therapy clinical outcome. Here, IFNA1 is linked to cyclic hematopoiesis.